Background: Dysarthria is a common sequel of nonprogressive brain damage (typically stroke and traumatic brain damage). Impairment-based therapy and a wide variety of compensatory management strategies are undertaken by speech and language therapists with this patient population.
Objective: To determine the efficacy of speech and language therapy interventions for adults with dysarthria following nonprogressive brain damage.
Design: Systematic review.
Search strategy: This review has drawn on the search strategies developed for the following Cochrane Groups as a whole: Stroke, Injuries, and Infectious Diseases. Relevant trials were identified in the Specialised Registers of Controlled Trials. We also searched the trials register of the Cochrane Rehabilitation and Related Therapies Field. The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, PsycLIT, and Linguistics and Language Behavior Abstracts were electronically searched. Hand-searching of the International Journal of Language and Communication Disorders and of reference lists from relevant articles and conference proceedings was also undertaken. Colleagues were approached to identify other possible published and unpublished studies.
Data collection and analysis: One reviewer assessed trial quality. Two co-reviewers were available to examine any potential trials for possible inclusion in the review.
Main results: No trials of the required standard were identified.
Reviewers' conclusions: There is no evidence of the quality required by this review to support or refute the effectiveness of speech and language therapy interventions for dysarthria following nonprogressive brain damage. There is an urgent need for good quality research in this area.
Sarno MT, Buonaguro A, Levita E. Characteristics of verbal impairment in closed head injured patients. Arch Phys Med Rehabil1986; 67: 400–405.
3.
Yorkston KM, Honsinger MJ, Mitsuda PM, Hammen V. The relationship between speech and swallowing disorders in head-injured patients. J Head Trauma Rehabil1989; 4: 1–16.
4.
Arboix A, Marti-Vilalta JL, Garcia JH. Clinical study of 227 patients with lacunar infarcts. Stroke1990; 21: 842–847.
5.
Melo TP, Bogousslavsky J, van Melle G, Regli F. Clinical messages Pure motor stroke: a reappraisal. Neurology1992; 42: 789–798.
6.
Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, Bamford JG, Wardlaw J. Stroke: a practical guide to management. Oxford: Blackwell Scientific, 1996.
7.
Netsell R. Physiological studies of dysarthria and their relevance to treatment. In: Rosenbek JC ed. Seminars in language. New York: Thieme-Stratton, 1984: 279–292.
8.
Yorkston KM, Beukelman DR, Bell KR. Clinical management of dysarthric speakers. London: Taylor and Francis, 1987.
9.
Tudor C, Selley WG. A palatal training appliance and a visual aid for use in the treatment of hypernasal speech. Br J Disord Commun1974; 9: 117–122.
10.
Crow E, Enderby P. The effects of an alphabet chart on the speaking rate and intelligiblity of speakers with dysarthria. In: Yorkston KM, Beukelman DR eds. Recent advances in clinical dysarthria. Boston: College-Hill, 1989: 99–108.
11.
McNamara R de P. A conceptual holistic approach to dysarthria treatment. In: Berry WR eds. Clinical dysarthria. San Diego, CA: College-Hill Press, 1983: 191–201.
12.
Berry WR, Sanders SB. Environmental education: the universal management approach for adults with dysarthria. In: Berry WR ed. Clinical dysarthria. San Diego, CA: College-Hill Press, 1983: 203–216.
13.
Fukusako Y, Endo K, Konno K et al. Changes in the speech of spastic dysarthric patients after treatment based on perceptual analysis. Ann Bull RILP1989; 23: 119–140.
14.
Ince LP, Rosenberg DN. Modification of articulation in dysarthria. Arch Phys Med Rehabil1973; 54: 233–236.
15.
Pilon MA, McIntosh KW, Thaut MH. Auditory versus visual speech timing cues as external rate control to enhance verbal intelligibility in mixed spastic-ataxic dysarthric speakers: a pilot study. Brain Injury1998; 12(9): 793–803.
16.
Yorkston KM, Beukelman DR. Ataxic dysarthria: treatment sequences based on intelligibility and prosodic considerations. J Speech Hear Dis1981; 46: 398–404.
17.
Cohen NS, Masse R. The application of singing and rhythmic instruction as a therapeutic intervention for persons with neurogenic communication disorders. J Music Ther1993; 30(2): 81–99.
18.
Enderby P, Crow E. Long-term recovery patterns of severe dysarthria following head injury. Br J Disord Commun1990; 25: 341–354.
19.
Keenan JE, Barnhart KS. Development of yes/no systems in individuals with severe traumatic brain injuries. Augmentative Altern Commun1993; 9: 184–190.
20.
Yorkston KM, Hammen VL, Beukelman DR, Traynor CD. The effect of rate control on the intelligibility and naturalness of dysarthric speech. J Speech Hear Dis1990; 55: 550–560.
21.
Kent RD, Kent JF, Duffy J, Weismer G. The dysarthrias: speech–voice profiles, related dysfunctions, and neuropathology. J Med Speech-Lang Pathol1998; 6(4): 165–211.
22.
Kent RD, Duffy J, Kent JF, Vorperian HK, Thomas JE. Quantification of motor speech abilities in stroke: time-energy analyses of syllable and word repetition. J Med Speech-Lang Pathol1999; 7(2): 83–90.
23.
Greener J, Enderby P, Whurr R. Speech and language therapy for aphasia following stroke (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2000.
24.
Robey RR, Schultz MC, Crawford AB, Sinner CA. Single-subject clinical-outcome research: designs, data, effect sizes, and analyses. Aphasiology1999; 13(6): 445–473.
25.
Baum HM, Logemann JA, Stenzel BA. Initiating a clinical trials group in an increasingly managed care environment: successes and problems in establishing collaboration. Med Care Res Rev1999; 56 (suppl 2): 139–152.
